Scientific Reports,
Journal Year:
2023,
Volume and Issue:
13(1)
Published: Dec. 27, 2023
Abstract
In
2021,
the
International
Diabetes
Federation
(IDF)
reported
that
prevalence
of
diabetes
in
Pakistan
was
9.6%,
higher
than
global
average.
However,
adherence
to
treatment
guidelines,
e.g.,
American
Association
and
Endocrine
Society
prescription
patterns
for
Oral
anti-diabetes
(OAD),
is
poorly
understood
Pakistan.
Therefore,
this
study
aimed
examine
prescribing
practices
anti-diabetic
medications,
an
association
lifestyle
modification
with
drugs
prescribed,
their
effectiveness
preserving
ideal
glycemic
levels
diabetic
patients
undergoing
tertiary
care
teaching
hospitals
rural
urban
cross-sectional
study,
data
were
collected
from
prescriptions
outpatient
different
between
October
2021
February
2022.
388
participants
enrolled
a
detailed
interview
on
evaluation
control.
The
coinvestigators
conducted
patient
used
pre-validated
questionnaire
collect
data.
relationship
following
guidelines
clinical
demographic
factors
found
using
chi-square
tests
bivariate
analyses.
out
388,
mean
ages
48
±
12.4,
majority
female.
It
observed
60.1%
66.5%
have
uncontrolled
fasting
random
blood
glucose,
respectively.
education
level
also
below
par
complete
understanding
medical
condition
self-management
therapy.
Even
though
they
taking
right
medications—an
average
regimen
included
5.08
medications—52.1%
studied
people
had
glycated
haemoglobin
(HbA1c)
therapeutic
threshold
set
by
Federation.
modern
era,
it
trend
still
focused
traditional
options
Biguanides,
sulfonylureas,
dipeptidyl
peptidase-4
inhibitors
prescribed
64.6%
patients.
A
significant
control
body
mass
index,
modifications,
number
medications
(p-value
<
0.05).
reveals
Pakistan's
do
not
align
international
national
leading
high
widespread
use
polypharmacy
among
To
address
issue,
policymakers
should
prioritize
establishing
comprehensive
action
plan.
Additionally,
there
pressing
need
develop
awareness
programs
emphasizing
importance
modifications
effective
management.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(3), P. 1517 - 1517
Published: Jan. 26, 2024
Diabetes
mellitus
is
a
devastating
chronic
metabolic
disease.
Since
the
majority
of
type
2
diabetes
patients
are
overweight
or
obese,
novel
term-diabesity-has
emerged.
The
gut-brain
axis
plays
critical
function
in
maintaining
glucose
and
energy
homeostasis
involves
variety
peptides.
Amylin
neuroendocrine
anorexigenic
polypeptide
hormone,
which
co-secreted
with
insulin
from
β-cells
pancreas
response
to
food
consumption.
Aside
its
effect
on
homeostasis,
amylin
inhibits
homeostatic
hedonic
feeding,
induces
satiety,
decreases
body
weight.
In
this
narrative
review,
we
summarized
current
evidence
ongoing
studies
mechanism
action,
clinical
pharmacology,
applications
analogs,
pramlintide
cagrilintide,
field
diabetology,
endocrinology,
metabolism
disorders,
such
as
obesity.
World Journal of Diabetes,
Journal Year:
2024,
Volume and Issue:
15(5), P. 797 - 809
Published: May 10, 2024
Childhood-onset
obesity
has
emerged
as
a
major
public
healthcare
challenge
across
the
globe,
fueled
by
an
obesogenic
environment
and
influenced
both
genetic
epigenetic
predispositions.
This
led
to
exponential
rise
in
incidence
of
type
2
diabetes
mellitus
children
adolescents.
The
looming
wave
diabetes-related
complications
early
adulthood
is
anticipated
strain
budgets
most
countries.
Unless
there
collective
global
effort
curb
devastation
caused
situation,
impact
poised
be
pro-found.
A
multifaceted
research
effort,
governmental
legislation,
effective
social
action
are
crucial
attaining
this
goal.
article
delves
into
current
epidemiological
landscape,
explores
evidence
concerning
potential
risks
consequences,
pathobiology
childhood
obesity,
discusses
latest
evidence-based
management
strategies
for
diabesity.
International Journal of Surgery,
Journal Year:
2024,
Volume and Issue:
110(10), P. 6214 - 6221
Published: Feb. 9, 2024
Roux-en-Y
gastric
bypass
(RYGB)
has
demonstrated
excellent
glycemic
control
and
type
2
diabetes
mellitus
(T2DM)
remission
for
patients
with
obesity
T2DM.
Duration
of
T2DM
is
a
consistent
negative
predictor
after
RYGB.
However,
the
exact
timing
to
offer
surgical
intervention
during
course
disease
not
well
elucidated.
Metabolites,
Journal Year:
2024,
Volume and Issue:
14(6), P. 327 - 327
Published: June 11, 2024
Several
hallmarks
of
metabolic
syndrome,
such
as
dysregulation
in
the
glucose
and
lipid
metabolism,
endothelial
dysfunction,
insulin
resistance,
low-to-medium
systemic
inflammation,
intestinal
microbiota
dysbiosis,
represent
a
pathological
bridge
between
syndrome
diabesity,
cardiovascular,
neurodegenerative
disorders.
This
review
aims
to
highlight
some
therapeutic
strategies
against
involving
integrative
approaches
improve
lifestyle
daily
diet.
The
beneficial
effects
foods
containing
antioxidant
polyphenols,
control,
physical
activity
were
also
considered.
We
comprehensively
examined
large
body
published
articles
basic,
animal,
human
studie,
well
recent
guidelines.
As
result,
dietary
polyphenols
from
natural
plant-based
antioxidants
adherence
Mediterranean
diet,
along
with
exercise,
are
promising
complementary
therapies
delay
or
prevent
onset
counteract
diabesity
cardiovascular
diseases,
protect
disorders
cognitive
decline.
Modulation
reduces
risks
associated
MS,
improves
diabetes
diseases
(CVD),
exerts
neuroprotective
action.
Despite
several
studies,
estimation
polyphenol
intake
is
inconclusive
requires
further
evidence.
Lifestyle
interventions
reduced
calorie
can
outcomes.
Trials,
Journal Year:
2025,
Volume and Issue:
26(1)
Published: Jan. 8, 2025
Physical
exercise
is
crucial
in
type
2
diabetes
management
(T2D),
and
training
the
aquatic
environment
seems
to
be
a
promising
alternative
due
its
physical
properties
metabolic,
functional,
cardiovascular,
neuromuscular
benefits.
Research
on
combined
dry-land
environments
scarce,
especially
long-term
interventions.
Thus,
this
study
aims
investigate
effects
of
both
health
outcomes
related
T2D
patients.
This
randomized,
unicentric,
single-blinded,
comparator
clinical
trial
with
two
parallel
arms.
Participants
T2D,
sexes,
aged
at
45
80
years
old,
will
randomized
into
groups
(aquatic
(AQUA)
(LAND)),
performing
aerobic
resistance
three
times
week
alternate
days
for
24
weeks.
Aerobic
performed
using
continuous
pyramidal
methods,
linear
intensity
duration
progression.
Intensity
prescribed
by
rated
effort
perception
(Borg
scale
6
20).
Resistance
trunk,
upper
lower
limbs
maximum
speed,
target
repetition
zone
environments,
respectively,
multiple
sets
dosage
Before,
12
weeks,
after
weeks
training,
biochemical
analyses,
functional
capacity,
muscle
strength,
body
composition
assessments,
cardiovascular
measures,
administration
questionnaires
assess
mental,
cognitive,
sleep
quality,
quality
life
conducted.
Throughout
load
date
acute
capillary
glucose
blood
pressure
measurements
also
The
data
analyzed
SPSS
(29.0)
statistical
package,
significance
level
0.05.
For
intra-
inter-group
comparisons,
generalized
estimating
equations
applied
intention-to-treat
per-protocol
adopting
Bonferroni
post
hoc
test.
obtained
results
may
provide
insights
enhance
understanding
benefits
various
outcomes,
as
well
aspects
safety
considerations
training.
Moreover,
could
support
development
intervention
strategies
optimize
management.
Brazilian
Clinical
Trial
Registry
(ReBEC)
RBR-10fwqmfy.
Registered
April
16,
2024.
ANZ Journal of Surgery,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 9, 2025
Abstract
Background
To
determine
if
the
positive
outcomes
from
clinical
trials
regarding
safety
and
efficacy
of
metabolic
bariatric
surgery
are
reproducible
at
a
national
level.
Methods
A
longitudinal
registry‐based
observation
study
with
data
collected
all
persons
undergoing
in
Australia
28
February
2012–31
December
2021
including
122,567
index
patients
who
underwent
134,625
completed
procedures.
Main
Outcomes
Measures
Defined
adverse
90‐days
(unplanned
readmission,
intensive
care
admission
re‐operation;
death),
annual
change
weight
(percent
total
body
loss
(TBWL)),
diabetes
treatment
need
for
re‐operation.
Results
79.0%
participants
were
female.
Mean
age
on
day
was
44.0
years
(SD
11.8;
range
12.9‐87.9
years)
mean
BMI
41.7
kg/m2
7.6).
At
5‐years
one
anastomosis
gastric
bypass
had
TBWL
34.88%
8.67%),
roux‐en‐Y
30.73
%
9.47%);
sleeve
gastrectomy
26.5%
10.5%)
adjustable
bands
17.6%
12.1%).
3.6%
procedures
recorded
defined
event.
13,904
(13.6%)
primary
reported
being
treated
baseline.
No
medication
required
by
71.6%
(follow‐up
58%)
1‐year
61%
22%)
5‐years.
13
904
Conclusions
Metabolic
is
safe
induces
substantial
reduced
medications
real‐world.
ClinicalTrials.gov
ID
NCT03441451.
Deleted Journal,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 21, 2025
The
prevalence
of
obesity
has
increased
significantly
in
recent
years
and
is
a
causal
risk
factor
for
the
development
type
2
diabetes.
Moreover,
chronic
degenerative
joint
diseases
are
also
triggered
by
obesity.
Both
obesity-related
secondary
diseases-type
diabetes
disease-can
be
prevented
or
at
least
delayed
lifestyle
intervention
aimed
weight
reduction.
progression
these
can
favourably
influenced
radical
loss.
Diets
with
reduction
carbohydrates-a
so-called
"low-carb"
ketogenic
diet-appear
to
superior
low-fat
diet.
If
replacement
surgery
necessary,
preoperative
perioperative
interdisciplinary
care
team
experienced
therapists
from
fields
orthopaedics
obesity/type
required.
Düsseldorf
TeDia
model
network
Catholic
hospitals
takes
requirements
into
account
providing
such
patients
orthopaedic
centre
St.
Vinzenz
Hospital
West
German
Diabetes
Health
Centre
(WDGZ).
Patients
pronounced
mellitus
presented
preoperatively
WDGZ
on
an
outpatient
basis,
therapy
optimization
diabetic
metabolic
situation
initiated.
problems
persist
despite
changes
that
require
surgery,
provides
inpatient
diabetology
clinic
option
further
follow-up
care.